Immunocore Holdings PLC at Goldman Sachs Healthcare Conference Transcript

Jun 14, 2023 / 08:20PM GMT
Rajan Sharma - Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone. I'm Rajan Sharma. I'm one of the healthcare analysts here at Goldman Sachs. I'm pleased that we've got Immunocore to join us for a fireside this afternoon. We've got Bahija Jallal, who's the CEO; and Brian Di Donato, CFO.

Questions and Answers:

Rajan Sharma - Goldman Sachs Group, Inc., Research Division - Research Analyst

So maybe I'll pass it over to you guys. Could you just maybe introduce yourselves, give us a bit of background on yourselves and maybe make some high-level comments on the company and kind of the trajectory that you've been on over the last 12 months or so?

Bahija Jallal - Immunocore Holdings plc - CEO & Director

Sure. So thank you for having us. I'm Bahija Jallal. I'm the CEO of Immunocore. I joined almost 4.5 years ago; was President of MedImmune/AstraZeneca for almost 13 years; and before that, was in the Bay Area, Sugen and Chiron. Yes, I joined the company for really the outstanding
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot